EV Biologics, Inc. (YECO)
OTCMKTS
· Delayed Price · Currency is USD
0.101
0.00 (0.00%)
At close: Jan 27, 2025
EV Biologics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2017 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | 2013 - 2012 |
---|---|---|---|---|---|---|
Period Ending | Dec '17 Dec 31, 2017 | Jun '17 Jun 30, 2017 | Jun '16 Jun 30, 2016 | Jun '15 Jun 30, 2015 | Jun '14 Jun 30, 2014 | 2013 - 2012 |
Cash & Equivalents | 8.39 | 1.81 | 2.73 | 16.47 | 19.73 | Upgrade
|
Short-Term Investments | 4.02 | - | - | - | - | Upgrade
|
Cash & Short-Term Investments | 12.4 | 1.81 | 2.73 | 16.47 | 19.73 | Upgrade
|
Cash Growth | 583.85% | -33.67% | -83.40% | -16.53% | 240.65% | Upgrade
|
Accounts Receivable | 1.03 | 4.97 | 5.73 | 9.33 | 5.18 | Upgrade
|
Other Receivables | - | 0.02 | 0.02 | - | - | Upgrade
|
Receivables | 1.03 | 4.98 | 5.74 | 9.33 | 6.11 | Upgrade
|
Inventory | 0.13 | 0.21 | 0.36 | 0.36 | 0.42 | Upgrade
|
Prepaid Expenses | 0.11 | 0.08 | 0.11 | 0.37 | 0.07 | Upgrade
|
Restricted Cash | - | 0.5 | 0.5 | - | - | Upgrade
|
Other Current Assets | 38.38 | 1.33 | 1.21 | 0.3 | 0.41 | Upgrade
|
Total Current Assets | 52.05 | 8.91 | 10.66 | 26.84 | 26.75 | Upgrade
|
Property, Plant & Equipment | 5.16 | 6.66 | 7.43 | 41.27 | 34.38 | Upgrade
|
Other Intangible Assets | 1.75 | 2.07 | 2.16 | 4.91 | 2.83 | Upgrade
|
Long-Term Deferred Tax Assets | - | 0.16 | 0.39 | 0.52 | 0.19 | Upgrade
|
Other Long-Term Assets | - | 15.49 | 15.8 | 4.06 | 5.4 | Upgrade
|
Total Assets | 58.95 | 33.28 | 36.44 | 77.6 | 69.56 | Upgrade
|
Accounts Payable | 1.66 | 2.3 | 1.71 | 1.73 | 1.82 | Upgrade
|
Accrued Expenses | 0.08 | 0.42 | 0.44 | 0.29 | 0.22 | Upgrade
|
Short-Term Debt | 6.47 | 7.04 | 7.64 | 10.56 | 7.93 | Upgrade
|
Current Portion of Leases | - | 4.8 | 4.06 | 4.62 | 1.61 | Upgrade
|
Current Income Taxes Payable | - | 0.98 | 1.13 | 0.98 | 0.95 | Upgrade
|
Current Unearned Revenue | - | 4.45 | 2.57 | - | 0.4 | Upgrade
|
Other Current Liabilities | 8.51 | 9.57 | 7.6 | 12.63 | 0.68 | Upgrade
|
Total Current Liabilities | 16.72 | 29.56 | 25.15 | 30.81 | 13.62 | Upgrade
|
Long-Term Debt | - | - | - | - | 9.8 | Upgrade
|
Long-Term Leases | - | - | 0.03 | 0.14 | 0.07 | Upgrade
|
Other Long-Term Liabilities | - | - | - | - | 8.42 | Upgrade
|
Total Liabilities | 16.72 | 29.56 | 25.18 | 30.95 | 31.91 | Upgrade
|
Common Stock | 8.68 | 0 | 0 | 0.01 | 0.01 | Upgrade
|
Additional Paid-In Capital | 15.27 | 40.71 | 40.51 | 19.01 | 19.01 | Upgrade
|
Retained Earnings | 18.28 | -35.49 | -28.06 | 25.13 | 16.45 | Upgrade
|
Comprehensive Income & Other | - | -1.51 | -1.19 | 2.5 | 2.17 | Upgrade
|
Shareholders' Equity | 42.23 | 3.72 | 11.26 | 46.65 | 37.65 | Upgrade
|
Total Liabilities & Equity | 58.95 | 33.28 | 36.44 | 77.6 | 69.56 | Upgrade
|
Total Debt | 6.47 | 11.85 | 11.73 | 15.31 | 19.41 | Upgrade
|
Net Cash (Debt) | 5.94 | -10.03 | -9 | 1.16 | 0.32 | Upgrade
|
Net Cash Growth | - | - | - | 262.99% | - | Upgrade
|
Net Cash Per Share | 2.46 | -4.16 | -3.77 | 0.72 | 0.20 | Upgrade
|
Filing Date Shares Outstanding | 27.41 | 2.41 | 2.4 | 1.6 | 1.6 | Upgrade
|
Total Common Shares Outstanding | 2.41 | 2.41 | 2.4 | 1.6 | 1.6 | Upgrade
|
Working Capital | 35.33 | -20.65 | -14.49 | -3.97 | 13.14 | Upgrade
|
Book Value Per Share | 17.52 | 1.54 | 4.69 | 29.16 | 23.53 | Upgrade
|
Tangible Book Value | 40.49 | 1.65 | 9.1 | 41.74 | 34.82 | Upgrade
|
Tangible Book Value Per Share | 16.79 | 0.69 | 3.79 | 26.09 | 21.76 | Upgrade
|
Buildings | - | 24.24 | 24.74 | 17.96 | 8.24 | Upgrade
|
Machinery | - | 8.14 | 8.3 | 8.91 | 5.23 | Upgrade
|
Construction In Progress | - | 0.02 | 0.01 | 16.89 | 23.96 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.